Bandingkan Harga & Kinerja Ingria Pratama Capitalindo Tbk. (GRIA) vs Organon Pharma Indonesia Tbk. (SCPI)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Ingria Pratama Capitalindo Tbk. dan Organon Pharma Indonesia Tbk.: Ingria Pratama Capitalindo Tbk. diperdagangkan di Rp164 (kapitalisasi pasar 1,23 T, volume 24 jam 3,55 jt), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Ingria Pratama Capitalindo Tbk. jauh lebih besar — sekitar 11,8× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| GRIA | SCPI | |
|---|---|---|
Kapitalisasi Pasar | 1,23 T | 104,4 M |
Volume | 3,55 jt | — |
Lot | 35,52 rb | — |
Perputaran | 569,66 jt | — |
Harga Rata-rata | 160,38 | — |
Nilai Transaksi | 569,66 jt | — |
Harga Ekuilibrium Indikatif | 164 | — |
Volume Ekuilibrium Indikatif | 65 | — |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Ingria Pratama Capitalindo Tbk.
PT Ingria Pratama Capitalindo Tbk (the “Company”) was established based on Notarial Deed No. 04 dated 8 May 2013 of Euis Widari, S.H. The Company commenced its operationalactivity with purchases of land in 2017.
Selengkapnya di halaman GRIA →Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →
